TSCAN THERAPEUTICS INC (TCRX) Stock Cash Flow
NASDAQ:TCRX - Nasdaq - US89854M1018 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -111.30M | -89.22M | -66.22M | -48.63M | -26.13M | |||
| Depreciation Amortization | 4.68M | 5.36M | 5.14M | 3.33M | 1.23M | |||
| Change In Working Capital | -6.40M | 17.61M | -10.23M | -5.90M | 21.36M | |||
| Interest Paid | 3.01M | 3.00M | N/A | N/A | N/A | |||
| Other non cash items | 5.85M | 4.89M | 4.81M | 2.52M | 520.00K | |||
| OPERATING CASH FLOW | -107.18M | -61.36M | -66.50M | -48.68M | -3.02M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.40M | -3.15M | -4.23M | -9.94M | -4.24M | |||
| Other Investing Activity | -74.58M | -57.61M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -78.00M | -60.76M | -4.23M | -9.94M | -4.24M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 29.35M | N/A | N/A | |||
| Stock Issued/Repurchased | 163.10M | 135.44M | 130.00K | 189.67M | 290.00K | |||
| Other Financing Activity | N/A | 0.00 | -130.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 163.10M | 135.44M | 29.36M | 189.67M | 290.00K | |||
| CHANGE IN CASH | -22.07M | 13.33M | -41.37M | 131.05M | -6.97M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -107.18M | -61.36M | -66.50M | -48.68M | -3.02M | |||
| Capital Expenditure | -3.40M | -3.15M | -4.23M | -9.94M | -4.24M | |||
| FREE CASH FLOW | -110.58M | -64.50M | -70.73M | -58.62M | -7.26M | |||
All data in USD